X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ELDER PHARMA UNICHEM LAB/
ELDER PHARMA
 
P/E (TTM) x 21.9 -0.2 - View Chart
P/BV x 2.3 0.1 2,287.0% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 UNICHEM LAB   ELDER PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
ELDER PHARMA
Jun-14
UNICHEM LAB/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs334380 87.9%   
Low Rs174188 92.6%   
Sales per share (Unadj.) Rs146.9491.2 29.9%  
Earnings per share (Unadj.) Rs11.9-3.2 -373.8%  
Cash flow per share (Unadj.) Rs16.214.4 112.3%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.1376.5 27.9%  
Shares outstanding (eoy) m90.8420.54 442.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.70.6 299.0%   
Avg P/E ratio x21.4-89.3 -23.9%  
P/CF ratio (eoy) x15.719.7 79.6%  
Price / Book Value ratio x2.40.8 320.4%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0735,833 395.5%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5582,179 117.4%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34610,089 132.3%  
Other income Rs m192257 74.8%   
Total revenues Rs m13,53810,346 130.9%   
Gross profit Rs m1,639-792 -207.0%  
Depreciation Rs m390361 107.9%   
Interest Rs m292,756 1.0%   
Profit before tax Rs m1,412-3,653 -38.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-40-   
Extraordinary Inc (Exp) Rs m-353,713 -1.0%   
Tax Rs m293125 233.9%   
Profit after tax Rs m1,080-65 -1,653.3%  
Gross profit margin %12.3-7.8 -156.5%  
Effective tax rate %20.7-3.4 -605.0%   
Net profit margin %8.1-0.6 -1,249.8%  
BALANCE SHEET DATA
Current assets Rs m5,9799,240 64.7%   
Current liabilities Rs m2,4329,998 24.3%   
Net working cap to sales %26.6-7.5 -353.9%  
Current ratio x2.50.9 266.0%  
Inventory Days Days6346 136.2%  
Debtors Days Days6060 100.7%  
Net fixed assets Rs m6,40310,124 63.2%   
Share capital Rs m182206 88.3%   
"Free" reserves Rs m9,2935,582 166.5%   
Net worth Rs m9,5487,734 123.5%   
Long term debt Rs m2304,889 4.7%   
Total assets Rs m12,84322,882 56.1%  
Interest coverage x50.0-0.3 -15,380.5%   
Debt to equity ratio x00.6 3.8%  
Sales to assets ratio x1.00.4 235.7%   
Return on assets %8.611.8 73.4%  
Return on equity %11.3-0.8 -1,339.0%  
Return on capital %14.322.3 64.3%  
Exports to sales %29.23.0 961.5%   
Imports to sales %6.30.4 1,485.1%   
Exports (fob) Rs m3,900307 1,271.9%   
Imports (cif) Rs m84743 1,964.5%   
Fx inflow Rs m4,356307 1,420.9%   
Fx outflow Rs m1,162125 927.6%   
Net fx Rs m3,194181 1,761.8%   
CASH FLOW
From Operations Rs m1,11911,754 9.5%  
From Investments Rs m-853-561 152.2%  
From Financial Activity Rs m-334-6,762 4.9%  
Net Cashflow Rs m-684,432 -1.5%  

Share Holding

Indian Promoters % 50.1 39.6 126.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 7.5 201.3%  
FIIs % 3.0 16.8 17.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 36.1 87.8%  
Shareholders   20,176 16,479 122.4%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  DR. DATSONS LABS  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Lupin up 4%(01:30 pm)

After opening the day flat, share markets in India remained rangebound and are presently trading marginally above the dotted line.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS